Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality

E Emmanuel Stamatakis R Raaj K. Biswas (Mackenzie Wearables Research Hub, Charles Perkins Centre (E.S., R.K.B., N.A.K., A.S., M.N.A.)) N Nicholas A. Koemel A Angelo Sabag (Mackenzie Wearables Research Hub, Charles Perkins Centre (E.S., R.K.B., N.A.K., A.S., M.N.A.)) R Richard Pulsford (Public Health and Sports Science, Faculty of Health and Life Science, University of Exeter, UK (R.P.).) A Andrew J. Atkin A Afroditi Stathi S Sonia Cheng (School of Health Sciences, Faculty of Medicine and Health, University of Sydney, NSW, Australia (E.S., R.K.B., N.A.K., A.S., S.C., M.N.A.).) C Cecilie Thøgersen-Ntoumani J Joanna M. Blodgett (Institute of Sport Exercise and Health, Division of Surgery and Interventional Science, University College London, UK (J.M.B., M.H.).) A Adrian Bauman C Carlos Celis-Morales M Mark Hamer J Jason M.R. Gill (School of Cardiovascular and Metabolic Health, University of Glasgow, UK (C.C.-M, J.M.R.G.).) M Matthew N. Ahmadi

Abstract

BACKGROUND: Few middle-aged and older adults engage in regular leisure-time exercise. Incidental physical activity (IPA) encompasses activities of daily living outside the leisure-time domain. No dose-response study is available to guide IPA-focused interventions and guidelines. We examined the associations of device-assessed IPA intensities (vigorous [VIPA], moderate [MIPA], light [LIPA]) with major adverse cardiovascular events (MACE) and mortality, and we estimated the “health equivalence” of LIPA and MIPA against 1 minute of VIPA. METHODS: A total of 24 139 nonexercisers from the 2013 to 2015 UK Biobank accelerometry substudy (56.2% women) with a mean±SD age of 61.9±7.6 years were analyzed using a prospective cohort design. IPA energy expenditure and daily durations of VIPA, MIPA, and LIPA were calculated with a validated machine learning-based intensity classifier. MACE included incident stroke, myocardial infarction, and heart failure; CVD death; CVD mortality; and all-cause mortality. RESULTS: Analyses included 22 107 (MACE), 22 174 (CVD mortality), and 24 139 (all-cause mortality) participants, corresponding to 908/223/1071 events over 7.9 years of follow-up. IPA volume exhibited an L-shaped association with a nadir at ≈35 to 38 kJ·kg −1 ·d −1 , corresponding to hazard ratios of 0.49 (95% CI, 0.39–0.61) for MACE, 0.33 (95% CI, 0.22–0.52) for CVD mortality, and 0.31 (95% CI, 0.25–0.38) for all-cause mortality. Any amounts of VIPA or MIPA were associated with lower risk, with a plateau of ≈14 minutes per day (VIPA) and 34 to 50 minutes per day (MIPA). The median VIPA (4.6 min/d) and MIPA (23.8 min/d) durations were associated with CVD mortality hazard ratio of 0.62 (95% CI, 0.46–0.83) and 0.50 (95% CI, 0.31–0.80), respectively. LIPA showed a subtle inverse gradient which was statistically significant only for CVD mortality at levels >130 minutes per day. One minute of VIPA was equivalent to 2.8 (MACE) to 3.4 (CVD mortality) minutes of MIPA and 34.7 (CVD mortality) to 48.5 (MACE) minutes of LIPA. CONCLUSIONS: Any daily IPA amount of vigorous or moderate intensity was associated with lower CVD risk in a dose-response manner. LIPA had weak associations with all outcomes. One minute of vigorous or ≈3.0 to 3.5 minutes of moderate IPA was associated with a similar degree of lower CVD risk. Our findings highlight the potential cardiovascular health value of incidental physical activity, especially for people who struggle to do structured exercise.

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue 15
Published April 15, 2025
Pages 1063-1075
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (15)

E

Emmanuel Stamatakis

R

Raaj K. Biswas

Mackenzie Wearables Research Hub, Charles Perkins Centre (E.S., R.K.B., N.A.K., A.S., M.N.A.)

N

Nicholas A. Koemel

A

Angelo Sabag

Mackenzie Wearables Research Hub, Charles Perkins Centre (E.S., R.K.B., N.A.K., A.S., M.N.A.)

R

Richard Pulsford

Public Health and Sports Science, Faculty of Health and Life Science, University of Exeter, UK (R.P.).

A

Andrew J. Atkin

A

Afroditi Stathi

S

Sonia Cheng

School of Health Sciences, Faculty of Medicine and Health, University of Sydney, NSW, Australia (E.S., R.K.B., N.A.K., A.S., S.C., M.N.A.).

C

Cecilie Thøgersen-Ntoumani

J

Joanna M. Blodgett

Institute of Sport Exercise and Health, Division of Surgery and Interventional Science, University College London, UK (J.M.B., M.H.).

A

Adrian Bauman

C

Carlos Celis-Morales

M

Mark Hamer

J

Jason M.R. Gill

School of Cardiovascular and Metabolic Health, University of Glasgow, UK (C.C.-M, J.M.R.G.).

M

Matthew N. Ahmadi